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in a recent study. The biomass of vancomycin sensitive and vancomycin-resistant E. faecalis biofilms is markedly reduced following infection with the genetically engineered phage. [24] Passage of phage through the E. faecalis strain JH2-2 harboring a defective prophage produced a new strain with more antimicrobial efficacy. [25] Using bacteriophages singly, in cocktail or genetically engineering them, could be a promising approach for treating biofilms formed by bacteria. However, these are a few attempts which have been made to treat E. faecalis infection using phage therapy and no such study has been reported for treating enterococci infection by phages in chronic periodontitis.
In this study, an E. faecalis infecting phage was isolated from sewage, and its efficacy against biofilms formed by enterococci isolates obtained from chronic periodontitis patients was evaluated. The drug-resistant oral enterococci isolates of chronic periodontitis patients were from our previous study. [26] This cross-sectional study had observed a highly significant association of oral drug-resistant enterococci with biofilm formation. [26] 
mateRials and methods
This study was conducted at the Department of Microbiology in Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital, Panjab University, Chandigarh, from June 2016 to January 2017. In our previous study entitled "Biofilm formation by drug-resistant enterococci isolates obtained from chronic periodontitis patients" 46 enterococci were isolated from 100 patients (52 males and 48 females). The study was approved by the Ethics Committee of the Panjab University. The patients were informed of the study protocol and written consent was obtained as per the Indian Council of Medical Education and Research guidelines. Briefly, the bacterial sample was collected from the subgingival sites and two sterile paper points were inserted into each periodontal pocket for 15-30 s. The paper points were pooled and transferred immediately in a sterile transport medium (glucose azide broth, HiMedia Laboratories, Mumbai) and taken to the laboratory for microbiological analysis. The samples were inoculated onto the 5% defibrinated sheep blood agar (HiMedia Laboratories, Mumbai) and incubated in microaerophilic condition overnight. Every growth showing Gram-positive cocci, positive bile esculin, positive 6.5% NaCl test, catalase-negative was processed. Enterococci speciation was done by motility tests, pigmentation (on tryptic soy agar) and 1% carbohydrate fermentation tests (mannitol, sorbitol, arabinose, lactose, and glucose) as per standard microbiological guidelines. [27] Standard antibiotic discs of amoxicillin (10 µg), ciprofloxacin (10 µg), erythromycin (15 µg), vancomycin (30 µg), gentamycin (10 µg), and teicoplanin (30 µg) were obtained from HiMedia Laboratories, Mumbai, India. The antibiotic susceptibility of the test strains to different antibiotics was determined by Kirby-Bauer disc diffusion susceptibility testing technique of the Clinical and laboratory standards Institute. [28] The quality control strain used was E. faecalis (ATCC 29212).
The evaluation of biofilm formation was done by standard protocol using microtiter plate method. [29] The isolates were then cultured in nutrient agar stabs and stored at 4°C for this study. Bacterial strain-E. faecalis (ATCC29212) was grown in brain heart infusion (BHI) broth at 37°C under aerobic conditions. The nutrient agar stabs of bacterial strains stored at 4°C were revived in BHI broth and further used for screening by the phage.
Isolation of the phage
The phage was isolated from the sewage effluent of Panjab University, Chandigarh, by the method of Smith and Huggins. [30] The sewage water (50 ml) was collected in a sterile conical flask and treated with few drops of chloroform. To this, an equal volume of the lactic phage broth (HiMedia Laboratories, Mumbai) and 1 ml of the 24 h old broth culture of E. faecalis ATCC29212 culture was added and incubated at 37°C for 12-24 h in a shaker water bath. [30] After 12-24 h, the lysate was shaken with a few drops of chloroform for about 10 min, centrifuged at 10,000 rpm for 10 min. The supernatant was filtered through a 0.22 um pore size Acrodisc membrane filters (HiMedia Laboratories, Mumbai) to remove the bacteria and subjected to the plaque-forming unit (PFU) assay using the standard double-layer agar method. [31] Briefly, the lysate obtained was diluted in 5 ml BHI broth, plated using soft agar (0.6%) and overlaid with 0.5 ml test (10 9 CFU/ml) overnight culture and incubated at 37°C for 24 h. Plaque morphology was observed the next day. For the recovery of the phage, a single well-isolated plaque was picked and repeated twice to ensure the isolation of the phage-type. The phage was isolated. The lysate was then stored in BHI with chloroform (40 ml/L) at 4°C-6°C.
Propagation of phage
The concentration of PFU was determined according to the standard method. [31] Lysate was diluted in 10 fold dilutions in 5 ml of BHI soft agar (0.6%). 100 ul of an overnight culture of test strain was added to the tube and put on BHI agar plate. The number of plaques was counted and the initial concentration of 10 9 plaque-forming particles was obtained.
Transmission electron microscopy visualization
The enterococci phage solution was filtered with the Acrodisc filter to remove soluble biological macromolecule fragments of host bacteria. After washing three times with 0.1M ammonium acetate solution (pH 7.0), the retained phage solution was used directly for negative staining with 2% phosphotungstic acid. A transmission electron microscope (TEM) (FEI Tecnai, G 2 F20, Netherlands-analyzed at 120 KV) was used to capture the images. The classification of the phage was done according to the guidelines of the International Committee on Taxonomy of viruses.
Biofilm assays
Microtiter plate assay was performed for analyzing biofilm formation. [29] BHI broth containing 0.25% glucose was inoculated with test strains and incubated at 37°C overnight.
The overnight BHI broth cultures supplemented with glucose were diluted 1:20 in fresh BHI broth with glucose. Diluted strain (200 ul) was dispensed into triplicate wells in a single column of a sterile 96 well flat bottom plate and incubated at 37°C for48 h. Microtiter plate was gently tapped, and planktonic cells were removed. Phage was added to the wells at 10 9 PFU/well, and the plate was incubated for 24 h at 37°C. The microtiter plates were then washed three times with sterile phosphorus buffer saline (PBS). The plates were inverted and dried for 1 h at room temperature. 0.5% aqueous crystal violet solution (200 ul) was added to each well for 15 min. The wells were then washed thrice with sterile PBS to wash off the excess crystal violet. 80:20 (vol/vol) mixtures of ethyl alcohol and acetone (200 ul) was added to solubilized bound crystal violet. The absorbance of the extracted crystal violet was read at 550 nm automatic microplate reader (APW). A biofilm-forming bacteria Staphylococcus epidermidis was taken as positive control and nonbiofilm forming bacteria Salmonella typhi was taken as a negative control. All biofilm assays were repeated three times. The cutoff value (ODc) was established. The final optical density (OD) value of a tested strain was expressed as average OD value of the strain reduced by ODc value of the triplicate assays. [29] Statistical analysis SPSS software version 22(IBM corp, Armonk, NY, USA) was used for statistical analysis. T-test and Chi-square test were performed for data analysis. For comparison of biofilm formation with phage and biofilm formation without phage (data were normally distributed) paired t-test was carried out. P < 0.05 was considered to be statistically significant.
ResUlts

Isolation and determination of phage efficacy
E. faecalis phage was isolated from sewage water. The phage had lytic activity, which was seen by clear plaque formation on double-layer agar [ Figure 1 ]. TEM microscopy showed that the phage has a hexagonal head about 73 nm in diameter and a 100 nm long-tail thus being morphologically similar to phages belonging to Siphoviridae family [ Figure 2 ].
Determination of phage efficacy against biofilms of enterococci
Enterococci phage was tested against 48 h attached enterococci cells in 96 well plates. After phage treatment with an initial dose concentration equal to or higher than 10 2 PFU/well, phage significantly reduced the biofilm activity within 24 h of contact (P < 0.05) [ Figure 3a and b]. A difference of at least 5 log CFU/ml is noticeable in the control biofilm, and the phage treated biofilm. The one-step curve shows a linear line in control biofilm that is no reduction in the biofilm biomass whereas the one step curve of phage treated biofilm shows a significant reduction in the biofilm mass (P < 0.05) whereas biofilm formed by isolates of E. faecium shows no significant reduction in the presence of phage. Enterococci are able to colonize the oral cavity, particularly in patients with periodontitis or root canal infections associated with oral mucosal lesions and in immunocompromised patients. [32] It has been reported that patients with periodontitis have a more diverse combination of species as compared to healthy persons. [33] b a
The phage was isolated from the wastewater. It has been seen that wastewater is a rich source of phage isolation against multidrug-resistant bacteria. A recent study shows that the application of the wastewater isolated phage has promising results in controlling vancomycin-resistant E. faecium in the milk samples. [34] TEM of phage revealed an icosahedral head around 73 nm in diameter and more than 100 nm long tail similar to phages belonging to Siphoviridae family. [35] These phages are lytic infecting Gram-positive bacteria and seem to be a promising candidate against Gram-positive pathogens. [36, 37] The host range of phage was limited to E. faecalis and less to E. faecium. This high host specificity is common among phages and is beneficial that the phage does not harm the natural microbiome of the host as antibiotics do. In our previous cross-sectional study 46 enterococci isolates were obtained from subgingival samples collected from seventy periodontitis patients. No enterococci isolate was obtained from control group which consisted of 30 subjects. Based on the identification, the species of enterococci were E. faecalis 39 (84.78%) followed by E. faecium 7 (15.21%). [26] The quantitative microtitre assay for biofilm formation was positive in 39/46 (84.78%) isolates. The remaining isolates were nonbiofilm producers considered as negative. E. faecalis strain positive for biofilm production was (29/39) 71.8% and E. faecium was 25.6% (10/39) . Among the enterococci isolates tested for antimicrobial susceptibility by Kirby Bauer disc diffusion method resistance to erythromycin was 3/46 (6.5%), ciprofloxacin 4/46 (8.7%), tiecoplanin 6/46 (13.0%), amoxicillin 2/46 (4.3%), gentamycin 4/46 (8.7%), and vancomycin 6/46 (13.3%). [26] In this study, the ability of the phage to reduce enterococcal biofilm and growth was tested. The phage efficiently reduced the growth of enterococci by at least 5 log CFU/ml in laboratory broth. Biofilm formation is indirect evidence of adhesiveness and microtiter plate assay is the indirect way to measure adhesion of Enterococci. Survival advantages conferred by the biofilm community include resistance to phagocytosis and antimicrobial agents. [38] The use of phages could help in reducing the colonization of teeth surface by E. faecalis, particularly the ability of the phage to reduce the biofilm after a minimum 24 h of contact. The reduction of the E. faecalis growth and biofilm formation has been successfully tested by the use of other antimicrobial agents [39, 40] probiotic bacteria [41] and a genetic engineered bacteriophage. [42] This could overcome the narrow host range of the phage and thus result in more effective prevention of enterococci biofilm and periodontitis. A recent finding on bacteriophage availability for human application has shown that bacteriophages are more virulent to bacteria in human cells and less in bacterial cultures. [24] This should lead to further clinical research and application of bacteriophages as therapeutic agents in human applications.
The results support that bacteriophage is a promising strategy to conventional antibiotic treatment, particularly in the case of biofilm and multidrug-resistant strains. The phage was active on all enterococci tested, including the vancomycin, ciprofloxacin, erythromycin, teicoplanin, and gentamycin-resistant strains.
conclUsion
The narrow host range of enterococci phage is a disadvantage, but it has the ability to reduce enterococci growth and biofilm formation. This study strengthens the view that phage therapy is effective on multidrug-resistant enterococci. If the incidence of vancomycin-resistant enterococci increases, it could be a stand-alone therapy for infections fully resistant to antibiotics like vancomycin.
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